Medicare Enrolled
Dr. Anil Rastogi, MD
Cardiovascular Disease · Hemet, CA
Practice pattern: Electrophysiology & Cardiac
— Practice combining electrophysiology and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rastogi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rastogi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rastogi
Dr. Anil Rastogi is a cardiovascular disease specialist in Hemet, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rastogi performed 6,168 Medicare services across 2,824 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rastogi received a total of $9,339 from 40 pharmaceutical and/or device companies across 434 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rastogi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 14% volume in CA
$9,339 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,168
Medicare services
Top 14% in CA for cardiovascular disease
2,824
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~325 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,570 | $99 | $175 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,083 | $12 | $125 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
512 | $44 | $200 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
282 | $76 | $500 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
227 | $159 | $1,000 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
217 | $6 | $36 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
155 | $53 | $450 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
138 | $374 | $1,650 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
112 | $63 | $200 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
91 | $56 | $400 |
| Evaluation of implantable heart and blood vessel monitoring system This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity. |
89 | $37 | $100 |
| New patient office visit, complex (60-74 min) | 84 | $178 | $400 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
82 | $17 | $150 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
77 | $99 | $175 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
72 | $17 | $45 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
69 | $21 | $150 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
41 | $155 | $600 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
41 | $33 | $50 |
| Programming of multiple lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with multiple leads to ensure proper function. |
39 | $83 | $175 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 33 | $20 | $50 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
32 | $144 | $400 |
| Programming of dual lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function. |
23 | $74 | $150 |
| Ambulatory blood pressure monitoring, 1 day or longer This procedure involves wearing a device to record blood pressure over a day or longer. It includes analyzing the data, interpreting the results, and providing a report. |
21 | $36 | $400 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording, analyzing, and interpreting a continuous external electrocardiogram (EKG) over a period of more than 48 hours up to 7 days. |
20 | $228 | $400 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
20 | $142 | $225 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
19 | $21 | $200 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
19 | $735 | $1,200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.9% high complexity
18.3% medium
72.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,339
Total received (2018-2024)
Avg $1,334/year across 7 years
Top 29% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
434
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,997 (96.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$342 (3.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,490
2023
$1,666
2022
$1,245
2021
$1,037
2020
$561
2019
$1,186
2018
$2,153
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$170
Amgen Inc.
$143
Boehringer Ingelheim Pharmaceuticals, Inc.
$142
Corcept Therapeutics
$127
Lexicon Pharmaceuticals, Inc.
$112
Novartis Pharmaceuticals Corporation
$109
Merck Sharp & Dohme LLC
$95
Novo Nordisk Inc
$91
PFIZER INC.
$71
E.R. Squibb & Sons, L.L.C.
$68
SCPHARMACEUTICALS INC.
$67
Kiniksa Pharmaceuticals International, plc
$61
Actelion Pharmaceuticals US, Inc.
$45
CVRx, Inc.
$43
Boston Scientific Corporation
$38
Tactile Systems Technology Inc
$33
Esperion Therapeutics, Inc.
$29
Janssen Pharmaceuticals, Inc
$27
ABBVIE INC.
$18
Top 3 companies account for 30.6% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,444
Novartis Pharmaceuticals Corporation
$1,295
Boston Scientific Corporation
$873
Janssen Pharmaceuticals, Inc
$779
Boehringer Ingelheim Pharmaceuticals, Inc.
$541
AstraZeneca Pharmaceuticals LP
$487
CVRx, Inc.
$394
Merck Sharp & Dohme LLC
$389
SANOFI-AVENTIS U.S. LLC
$358
PFIZER INC.
$336
Esperion Therapeutics, Inc.
$313
ABBVIE INC.
$301
E.R. Squibb & Sons, L.L.C.
$218
Novo Nordisk Inc
$177
Lexicon Pharmaceuticals, Inc.
$153
Corcept Therapeutics
$127
GlaxoSmithKline, LLC.
$110
Abbott Laboratories
$109
Kiniksa Pharmaceuticals, Ltd.
$92
SCPHARMACEUTICALS INC.
$67
Edwards Lifesciences Corporation
$64
Bayer HealthCare Pharmaceuticals Inc.
$63
Kiniksa Pharmaceuticals International, plc
$61
Lantheus Medical Imaging, Inc.
$58
Amarin Pharma Inc.
$57
Gilead Sciences, Inc.
$48
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$47
Actelion Pharmaceuticals US, Inc.
$45
ARBOR PHARMACEUTICALS, INC.
$45
Inspire Medical Systems, Inc.
$43
Medtronic Vascular, Inc.
$43
Merck Sharp & Dohme Corporation
$38
Tactile Systems Technology Inc
$33
iRhythm Technologies, Inc.
$28
Allergan Inc.
$23
Genentech USA, Inc.
$18
Dexcom, Inc.
$18
BIOTRONIK INC.
$17
Bayer Healthcare Pharmaceuticals Inc.
$14
Arbor Pharmaceuticals, Inc.
$14
Top 3 companies account for 38.7% of all-time payments
Associated products mentioned in payments ›
Activase · Arcalyst · BRILINTA · BYSTOLIC · Barostim Neo System · CHANTIX · CoreValve Evolut · Corlanor · DEXCOM G6 CGM SYSTEM · Definity · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · Edarbi · Edarbyclor · Edora · Edwards SAPIEN 3 Transcatheter Heart Valve · Ensite Cardiac Mapping System · FARXIGA · FUROSCIX · Flexitouch Plus · INSPIRE · Inpefa · JARDIANCE · Kerendia · Korlym · LEQVIO · LOKELMA · LifeVest · MULTAQ · Micra · Mitra Clip system · MitraClip System · NEXLETOL · Ozempic · PRADAXA · PRALUENT · QULIPTA · Repatha · Rybelsus · STIOLTO RESPIMAT · TRELEGY ELLIPTA · UBRELVY · UPTRAVI · VERQUVO · VRAYLAR · VYNDAMAX · VYNDAQEL · Vascepa · Verquvo · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · Xience Alpine cornary stent system · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
35
Per 100K population
1.4
County median income
$89,672
Nearest hospital
HEMET GLOBAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rastogi is an electrophysiology & cardiac specialist, with above-average Medicare volume (top 14% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rastogi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rastogi performed 2,570 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rastogi receive payments from pharmaceutical companies?
Yes. Dr. Rastogi received a total of $9,339 from 40 companies across 434 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rastogi's costs compare to other cardiologists in Hemet?
Dr. Rastogi's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rastogi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Hemet
Browse cardiologists in Hemet ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology